Scratching the surface

Oppilotech’s model finds new targets for Gram-negative antibiotic potentiators

Oppilotech Ltd. is using computational modeling to develop first-in-class compounds that can permeate the lipopolysaccharide layer of the outer cell membrane of Gram-negative bacteria to potentiate existing antibiotics.

Marketed polymyxins are used to disrupt the lipopolysaccharide (LPS) to treat Gram-negative infections, but they have neurotoxic and nephrotoxic side effects that limit use to last resort cases.

“What polymyxins do is more like

Read the full 614 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE